AU7990000A - Neuraminidase inhibitors - Google Patents

Neuraminidase inhibitors

Info

Publication number
AU7990000A
AU7990000A AU79900/00A AU7990000A AU7990000A AU 7990000 A AU7990000 A AU 7990000A AU 79900/00 A AU79900/00 A AU 79900/00A AU 7990000 A AU7990000 A AU 7990000A AU 7990000 A AU7990000 A AU 7990000A
Authority
AU
Australia
Prior art keywords
neuraminidase inhibitors
neuraminidase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79900/00A
Inventor
Vincent L. Giranda
Yu Gui Gu
Stephen Hanessian
Dale J. Kempf
Allan C. Krueger
Clarence J. Maring
Vincent S. Stoll
Minghua Sun
Gary T Wang
Jianchio Wang
Chen Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU7990000A publication Critical patent/AU7990000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU79900/00A 1999-10-19 2000-10-02 Neuraminidase inhibitors Abandoned AU7990000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41986399A 1999-10-19 1999-10-19
US09419863 1999-10-19
US42810799A 1999-10-27 1999-10-27
US09428107 1999-10-27
PCT/US2000/027125 WO2001029021A1 (en) 1999-10-19 2000-10-02 Neuraminidase inhibitors

Publications (1)

Publication Number Publication Date
AU7990000A true AU7990000A (en) 2001-04-30

Family

ID=27024653

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79900/00A Abandoned AU7990000A (en) 1999-10-19 2000-10-02 Neuraminidase inhibitors

Country Status (3)

Country Link
AU (1) AU7990000A (en)
BR (1) BR0010622A (en)
WO (1) WO2001029021A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
CN100471848C (en) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 Long-chain alkoxy alkyl substituted sialic acid derivatives and preparing method thereof
NL2013420B1 (en) * 2014-09-05 2016-09-27 Univ Griffith Antiviral agents and uses thereof.
WO2024026536A1 (en) * 2022-08-03 2024-02-08 Griffith University Antiviral compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus

Also Published As

Publication number Publication date
WO2001029021A1 (en) 2001-04-26
BR0010622A (en) 2003-07-15

Similar Documents

Publication Publication Date Title
GB9900416D0 (en) Inhibitors
AU2002219555A1 (en) VLA-4 Inhibitors
AU1173201A (en) Skin-gripper
AU3074500A (en) Proteasome inhibitors
AU8673598A (en) Neuraminidase inhibitors
AU7125700A (en) Enzyme inhibitors
AU3235100A (en) Prothease inhibitors
GB9924522D0 (en) Enzyme inhibitors
AU3761400A (en) Amino-thio-acrylonitriles as mek inhibitors
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU1588901A (en) Protease inhibitors
AU2699800A (en) Organoceramics
AU1474801A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors
AU7957000A (en) Cyclooxygenase-2 expression inhibitors
AU7127000A (en) Enzyme inhibitors
AU7990000A (en) Neuraminidase inhibitors
AU7608100A (en) 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
AU7887100A (en) Corrosion inhibitor
AU7127100A (en) Enzyme inhibitors
AU5787901A (en) Compound

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase